A Pilot Prospective Study of the Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI), Diffusion Weighted MRI (DWI)and Positron Emission Tomography (PET) Imaging With 18F-Fluorodeoxyglucose (18FDG) in Brachytherapy for Cervix Cancer
The standard treatment for cervix cancer at Princess Margaret Hospital is external radiation
with chemotherapy followed by internal radiation, called brachytherapy. Currently,
brachytherapy treatment is planned on a type of Magnetic Resonance Imaging (MRI) called
T2-weighted (T2W) MRI.
The main purpose of this study is to determine whether the following imaging tests can
visualize the tumour better for planning the brachytherapy treatment:
1. special types of MRI called diffusion weighted MRI (DWI) and dynamic-contrast enhanced
MRI (DCE-MRI); and
2. an x-ray test called positron emission test (PET) performed with a sugar dye called
FDG. MRI-guided brachytherapy is resource-intensive and not widely available.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society